Incannex Healthcare (IXHL) News Today $1.68 -0.11 (-5.88%) (As of 12/20/2024 05:16 PM ET) Add Compare Share Share Headlines Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 Time Period Financial Contrast: Incannex Healthcare (IXHL) vs. The CompetitionDecember 14, 2024 | americanbankingnews.comIncannex Healthcare (NASDAQ:IXHL) Shares Up 5.5% - Still a Buy?Incannex Healthcare (NASDAQ:IXHL) Shares Up 5.5% - Still a Buy?November 19, 2024 | marketbeat.comIncannex Healthcare Reports Q3 Loss, Secures New FundingNovember 19, 2024 | markets.businessinsider.comRFK and the 'MAHA Trade': Vaccine makers down, psychedelic shares upNovember 16, 2024 | msn.comIncannex Healthcare Inc. Reports Fiscal First Quarter 2025 Financial Results and Business UpdatesNovember 14, 2024 | globenewswire.comIncannex Healthcare Leads The Charge On US Penny Stocks With 2 Other Notable PicksOctober 24, 2024 | finance.yahoo.comIncannex Announces Appointment of Dr. Lou Barbato as Chief Medical OfficerOctober 24, 2024 | globenewswire.comIncannex Healthcare (NASDAQ:IXHL) Stock, Short Interest ReportOctober 5, 2024 | benzinga.comIncannex Healthcare Inc. Reports Fiscal Full Year 2024 Financial Results and Business UpdatesSeptember 30, 2024 | globenewswire.comIncannex Healthcare Inc. (NASDAQ:IXHL) Short Interest UpdateIncannex Healthcare Inc. (NASDAQ:IXHL - Get Free Report) was the recipient of a significant growth in short interest in August. As of August 31st, there was short interest totalling 113,400 shares, a growth of 72.3% from the August 15th total of 65,800 shares. Approximately 0.9% of the shares of the company are sold short. Based on an average trading volume of 31,100 shares, the days-to-cover ratio is presently 3.6 days.September 13, 2024 | marketbeat.comIncannex Healthcare Announces Strategic Financing for up to $60 Million with Arena InvestorsSeptember 10, 2024 | finance.yahoo.comFDA Review of PsiGAD2 IND complete; clinical trial for Psilocybin Assisted Psychotherapy in Patients with Generalised Anxiety Disorder to ProceedAugust 5, 2024 | globenewswire.comTidal Investments LLC Acquires Shares of 423,410 Incannex Healthcare Inc. (NASDAQ:IXHL)Tidal Investments LLC acquired a new stake in Incannex Healthcare Inc. (NASDAQ:IXHL - Free Report) during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund acquired 423,410 shares of the company's stock, valued at approximately $1,52August 4, 2024 | marketbeat.comDosing completed in 115 participant bioavailability/bioequivalence clinical trial for proprietary sleep apnea drug candidate IHL-42XJuly 30, 2024 | globenewswire.comIncannex Healthcare Inc. (NASDAQ:IXHL) Sees Significant Growth in Short InterestIncannex Healthcare Inc. (NASDAQ:IXHL - Get Free Report) saw a large growth in short interest in the month of July. As of July 15th, there was short interest totalling 14,000 shares, a growth of 100.0% from the June 30th total of 7,000 shares. Currently, 0.1% of the shares of the stock are sold short. Based on an average trading volume of 25,600 shares, the short-interest ratio is presently 0.5 days.July 27, 2024 | marketbeat.comIncannex Healthcare Inc. (NASDAQ:IXHL) Short Interest Down 69.0% in JuneIncannex Healthcare Inc. (NASDAQ:IXHL - Get Free Report) was the recipient of a significant decline in short interest in June. As of June 30th, there was short interest totalling 7,000 shares, a decline of 69.0% from the June 15th total of 22,600 shares. Approximately 0.1% of the shares of the stock are short sold. Based on an average daily trading volume, of 25,600 shares, the days-to-cover ratio is presently 0.3 days.July 11, 2024 | marketbeat.comIncannex Healthcare Inc. (NASDAQ:IXHL) Short Interest Down 32.9% in JuneIncannex Healthcare Inc. (NASDAQ:IXHL - Get Free Report) was the target of a significant drop in short interest in June. As of June 15th, there was short interest totalling 22,600 shares, a drop of 32.9% from the May 31st total of 33,700 shares. Currently, 0.2% of the shares of the stock are sold short. Based on an average daily volume of 28,200 shares, the days-to-cover ratio is currently 0.8 days.June 29, 2024 | marketbeat.comPatient dosing commenced in RePOSA Phase 2/3 Clinical Trial Protocol to Assess IHL-42X Drug in Patients with Obstructive Sleep ApneaMay 30, 2024 | globenewswire.comIncannex Healthcare Inc. (NASDAQ:IXHL) Short Interest Up 31.3% in AprilIncannex Healthcare Inc. (NASDAQ:IXHL - Get Free Report) saw a significant increase in short interest during the month of April. As of April 30th, there was short interest totalling 54,900 shares, an increase of 31.3% from the April 15th total of 41,800 shares. Based on an average daily volume of 306,200 shares, the short-interest ratio is presently 0.2 days. Currently, 0.5% of the company's shares are sold short.May 15, 2024 | marketbeat.comIncannex Healthcare: Incannex Complete Successful Pre-IND Meeting with the FDA for CannQuit-O for treatment of opioid use disorderMay 7, 2024 | finanznachrichten.deIncannex Complete Successful Pre-IND Meeting with the FDA for CannQuit-O for treatment of opioid use disorderMay 7, 2024 | globenewswire.comPsyched: 5-MeO-DMT For Depression, Utah Hospitals Providing Therapy, Elon Musk And Meta's InfluenceMarch 29, 2024 | msn.comShort Interest in Incannex Healthcare Inc. (NASDAQ:IXHL) Grows By 113.1%Incannex Healthcare Inc. (NASDAQ:IXHL - Get Free Report) was the target of a significant growth in short interest in the month of March. As of March 15th, there was short interest totalling 208,200 shares, a growth of 113.1% from the February 29th total of 97,700 shares. Based on an average daily trading volume, of 309,800 shares, the short-interest ratio is presently 0.7 days. Approximately 1.8% of the company's shares are short sold.March 28, 2024 | marketbeat.comIncannex Healthcare Inc IXHLMarch 24, 2024 | morningstar.comPsychedelic-Assisted Therapy Advancements Create A New Horizon For Mental Health In ColoradoMarch 22, 2024 | msn.comTrading was temporarily halted for "IXHL" at 03:03 PM with a stated reason of "LULD pause." Trading set to resume at 04:03 PM. March 19, 2024 | marketbeat.comIncannex Healthcare Inc. (NASDAQ:IXHL) Short Interest Up 57.3% in FebruaryIncannex Healthcare Inc. (NASDAQ:IXHL - Get Free Report) was the recipient of a large increase in short interest in the month of February. As of February 15th, there was short interest totalling 97,200 shares, an increase of 57.3% from the January 31st total of 61,800 shares. Based on an average trading volume of 94,300 shares, the short-interest ratio is presently 1.0 days. Approximately 0.6% of the company's shares are sold short.March 3, 2024 | marketbeat.comIncannex's Phase 2 Psi-GAD1 Trial Of Psilocybin Meets Primary Endpoint; Stock Surges 39%February 28, 2024 | markets.businessinsider.comNovavax, Applied Therapeutics, Incannex among healthcare moversFebruary 28, 2024 | msn.comIncannex Announces Positive Topline Results from Phase 2 Psi-GAD1 Clinical Trial of Psilocybin in Generalised Anxiety DisorderFebruary 28, 2024 | finance.yahoo.comTrading was temporarily halted for "IXHL" at 09:02 AM with a stated reason of "LULD pause."February 28, 2024 | marketbeat.comTrading was temporarily halted for "IXHL" at 09:02 AM with a stated reason of "LULD pause." Trading set to resume at 09:02 AM. February 28, 2024 | marketbeat.comTrading was temporarily halted for "IXHL" at 12:02 PM with a stated reason of "LULD pause."February 21, 2024 | marketbeat.comTrading was temporarily halted for "IXHL" at 12:02 PM with a stated reason of "LULD pause." Trading set to resume at 12:02 PM. February 21, 2024 | marketbeat.comIncannex Healthcare: Incannex Completes Successful Pre-IND Meeting with the FDA for CannQuit-N; a Novel Solution for Tobacco Smoking CessationFebruary 16, 2024 | finanznachrichten.deIncannex Completes Successful Pre-IND Meeting with the FDA for CannQuit-N; a Novel Solution for Tobacco Smoking CessationFebruary 16, 2024 | finance.yahoo.comIncannex Completes Successful Pre-IND Meeting with the FDA for CannQuit-N; a Novel Solution for Tobacco Smoking CessationFebruary 16, 2024 | globenewswire.comWe're Keeping An Eye On Incannex Healthcare's (NASDAQ:IXHL) Cash Burn RateFebruary 4, 2024 | finance.yahoo.comIncannex Healthcare begins dosing in Phase 2 clinical trial...February 1, 2024 | proactiveinvestors.comClarion Clinics Open for Psychedelic-Assisted TreatmentsFebruary 1, 2024 | finance.yahoo.comPodcast: International Cannabis And Psychedelics Co. Is Working 'Hand In Hand' With FDA To Forge New Therapy FrontiersJanuary 25, 2024 | msn.comIncannex Commences Dosing in Phase 2 Clinical Trial Assessing IHL-675A in Patients with Rheumatoid ArthritisJanuary 24, 2024 | finance.yahoo.comIncannex Completes Dosing and Therapy in Phase 2 “PsiGAD” Clinical Trial Assessing Psilocybin-assisted Psychotherapy for Generalized Anxiety Disorder; Data Analysis CommencesJanuary 18, 2024 | finance.yahoo.comIncannex Receives IRB Approval for the RePOSA Phase 2/3 Clinical Trial Protocol to Assess IHL-42X Drug in Patients with Obstructive Sleep ApneaJanuary 17, 2024 | finance.yahoo.comIXHL Incannex Healthcare Inc.January 14, 2024 | seekingalpha.comShort Interest in Incannex Healthcare Inc. (NASDAQ:IXHL) Grows By 107.5%Incannex Healthcare Inc. (NASDAQ:IXHL - Get Free Report) was the recipient of a large growth in short interest in December. As of December 31st, there was short interest totalling 93,600 shares, a growth of 107.5% from the December 15th total of 45,100 shares. Based on an average daily volume of 65,000 shares, the short-interest ratio is currently 1.4 days. Currently, 0.0% of the shares of the stock are short sold.January 12, 2024 | marketbeat.comIncannex Healthcare Inc. (NASDAQ:IXHL) Sees Significant Increase in Short InterestIncannex Healthcare Inc. (NASDAQ:IXHL - Get Free Report) saw a significant increase in short interest in the month of December. As of December 15th, there was short interest totalling 45,100 shares, an increase of 705.4% from the November 30th total of 5,600 shares. Based on an average trading volume of 62,900 shares, the days-to-cover ratio is presently 0.7 days. Currently, 0.0% of the shares of the stock are short sold.December 28, 2023 | marketbeat.comPsyched: Biden Approves Psychedelics Trials, RFK, Australia's First Legal Dedicated Clinic & MoreDecember 27, 2023 | msn.comIncannex Healthcare Stock (NASDAQ:IXHL) Dividends: History, Yield and DatesDecember 24, 2023 | benzinga.comIncannex Healthcare To Open First Psychedelic-Assisted Therapy Clinic In AustraliaDecember 23, 2023 | msn.com Get Incannex Healthcare News Delivered to You Automatically Sign up to receive the latest news and ratings for IXHL and its competitors with MarketBeat's FREE daily newsletter. Email Address Could This Tiny Device Help You Make an Extra $30k a Year? (Ad)I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more than $9 trillion. That’s nearly 10 times more money than the market caps of Tesla… SpaceX… PayPal… Neuralink… and X… COMBINED. Click here to see the details because I believe a lot of people will get rich. IXHL Media Mentions By Week IXHL Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. IXHL News Sentiment▼0.000.61▲Average Medical News Sentiment IXHL News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. IXHL Articles This Week▼00▲IXHL Articles Average Week Get Incannex Healthcare News Delivered to You Automatically Sign up to receive the latest news and ratings for IXHL and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Protalix BioTherapeutics News Cassava Sciences News Inventiva News Editas Medicine News Aligos Therapeutics News Acumen Pharmaceuticals News Metagenomi News Leap Therapeutics News Protara Therapeutics News INmune Bio News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:IXHL) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Incannex Healthcare Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Incannex Healthcare With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
